Protocol digest of a phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery-hyperintense lesion on MRI for newly diagnosed supratentorial glioblastoma: JCOG2209 (FLAMINGO)
Yuta Sekino(Japan Clinical Cancer Research Organization), Yoshitaka Narita(Unknown), Haruhiko Fukuda(National Cancer Center Hospital East), Koichi Ichimura(Kyorin University), Junki Mizusawa(Japan Clinical Cancer Research Organization), Hiroshi Igaki(National Cancer Centre Japan), Yoshiki Arakawa(Kyoto Prefectural University of Medicine), Yukihiko Sonoda(Yamagata University), Tetsuya Sekita(Keio University), Ichiyo Shibahara(Kitasato University), Manabu Kinoshita(Asahikawa Medical University), Mayumi Ichikawa(Yamagata University), Keita Sasaki(Sumitomo Electric Industries (United States)), Toshihiro Kumabe(Kitasato University), Junji Shibahara(Kyorin University)
Cited by 3
Related Papers
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780